Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
Covid19
About this trial
This is an interventional prevention trial for Covid19 focused on measuring ventilation, air filtration, Covid19, SARS CoV 2, household transmission
Eligibility Criteria
Inclusion Criteria: Household members live in a shared space (apartment, home) with others (as opposed to renting single rooms in a shared space, for example) At least 3 other people live in the household aside from index case Exclusion Criteria: If index case test positive day was over 2 days prior If half or more household members are thought to be infected already If household has fewer than 3 contacts interested in participating in the study If fewer than 3 contacts are expected to be present in the house for a majority of the following 7 days
Sites / Locations
- San Mateo Medical Center
- Stanford University Medical Center
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Intervention
No intervention will be administered in this arm. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will provide a link to the basic CDC isolation guidelines which would be part of standard of care. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts.
Families are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts.